Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) and Nanovibronix (NASDAQ:FEED – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation.
Valuation & Earnings
This table compares Green Thumb Industries and Nanovibronix”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Green Thumb Industries | $1.18 billion | 1.09 | $114.15 million | $0.54 | 12.15 |
| Nanovibronix | $1.93 million | 0.12 | -$18.18 million | ($117.28) | -0.00 |
Profitability
This table compares Green Thumb Industries and Nanovibronix’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Green Thumb Industries | 10.48% | 6.03% | 4.09% |
| Nanovibronix | -1,093.61% | -60.73% | -48.48% |
Volatility and Risk
Green Thumb Industries has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Nanovibronix has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Green Thumb Industries and Nanovibronix, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Green Thumb Industries | 0 | 1 | 1 | 1 | 3.00 |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
Green Thumb Industries presently has a consensus target price of $18.00, indicating a potential upside of 174.39%. Given Green Thumb Industries’ stronger consensus rating and higher possible upside, analysts plainly believe Green Thumb Industries is more favorable than Nanovibronix.
Institutional and Insider Ownership
0.1% of Green Thumb Industries shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 9.4% of Green Thumb Industries shares are owned by company insiders. Comparatively, 12.2% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Green Thumb Industries beats Nanovibronix on 12 of the 15 factors compared between the two stocks.
About Green Thumb Industries
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.
